Fatal or Near-Fatal Asthma: Clinical Entity or Incorrect Management?;Asma Fatal o Casi Fatal: ¿Entidad Clínica o Manejo Inadecuado?

Archivos de Bronconeumologia

Volumn 40, Issue 1, 2004, Pages 24-33

  Rodrigo, G J ^a   Rodrigo, C ^b   Nannini, L J ^c  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b Unidad de Cuidado Intensivo   (Uruguay)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE;

ASTHMA; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FORCED EXPIRATORY VOLUME; HUMAN; PATHOPHYSIOLOGY; REVIEW;

EID: 1042300085     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056083     Document Type: Review

References (130)

1. British Thoracic Society and Scottish Intercollegiate Guidelines Network. National Institutes of Health. Global initiative for asthma: global strategy for asthma management and prevention. National Heart, Lung, and Blood Institute. Bethesda, MD: 02-5075, 2002; p. 133-42.
2. British Thoracic Society and others. Guidelines on the management of asthma. Management of acute asthma. Thorax 2003;58:32-50.
3. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISA-AC). Eur Respir J 1998;12:315-35.
4. Surveillance for asthma: United States, 1960-1995. MMWR Morb Mortal Wkly Rep 1998;47:1-27.
5. Self-report asthma prevalence among adults-United States 2000. MMWR Morb Mortal Wkly Rep 2001;50:682-6.
6. Rea HH, Seragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax 1986;41:833-9.
7. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998;157:1804-9.
8. Plaza V, Serrano J, Picado C, Sanchís J. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002;19:846-52.
9. Beasley R, Pearce N, Crane J. Use of near fatal asthma for investigating asthma deaths. Thorax 1993;48:1093-4.
10. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis 1990;142:108-11.
11. Molfino NA. Near-fatal asthma. In: Hall JB, Corbridge T, Rodrigo C, Rodrigo GJ, editores. Acute asthma. Assessment and management. New York: McGraw-Hill, 2000; p. 29-47.
12. Nannini LJ. Morbidity and mortality from acute asthma. En: Hall JB, Corbridge T, Rodrigo C, Rodrigo GJ, editores. Acute asthma. Assessment and management. New York: McGraw-Hill, 2000; p. 11-27.
13. Abramson MJ, Bailey MJ, Couper FJ, Driver JS, Drummer OH, Forbes AB, et al. Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med 2001;163:12-8.
14. Emerman CL, Cydulka RK, Skobeloff E. Survey of asthma practice among emergency physicians. Chest 1996;109:708-12.
15. Kolbe J, Vamos M, Fergusson W, Elkind G. Determinants of management errors in acute severe asthma. Thorax 1998;53:14-20.
16. Pinnock H, Johnson A, Young P, Martin N. Are doctors still failing to assess and treat asthma attacks? An audit of the management of acute attacks in a health district. Respir Med 1999;93:397-401.
17. Salmeron S, Liard R, Elkharrat D, Muir JJ, Neukirch F, Ellrodt A. Asthma severity adequacy of management in accident and emergency departments in France: a prospective study. Lancet 2001;358:629-35.
18. Burt CW, Knapp DE. Ambulatory care visits for asthma: United States, 1993-1994. Adv Data 1996;277:1.
19. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922;30:689-760.
20. Bullen SS. Correlation of clinical and autopsy findings in 176 cases of asthma. J Allergy 1952;23:193-203.
21. Williams DA. Deaths from in England and Wales. Thorax 1953;8:137-40.
22. Houston JC, De Navasquez S, Trounce JR. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 1953;8:195-206.
23. Speizer FE, Doll R, Heaf P. Observations on recent increase in mortality from asthma. BMJ 1968;1:335-9.
24. Speizer FE, Doll R, Heaf P, Strang LB. An investigation into use of drugs preceding death from asthma. BMJ 1968;1:339-43.
25. Inman WHW, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurized aerosols. Lancet 1969;2:279-85.
26. National Health Statistics Centre. New Zealand health statistics report-mortality and demographic data, 1959-1979. Wellington, New Zealand: NHSC Department of Health Annual Reports.
27. Commonwealth Bureau of Census and Statistics. Causes of death-Australia 1968-1979. Canberra, Australia; CBCS Annual Reports.
28. Gandevia B. The changing pattern of mortality from asthma in Australia. Med J Aust 1968;1:747-52.
29. Sears MR, Rea HH, Beaglehole R, Gillies AJ, Holst PE, O'Donnell TV, et al. Asthma mortality in New Zealand: a two year national study. NZ Med J 1985;98:271-5.
30. Beaglehole R, Jackson R, Sears M, Rea H. Asthma mortality in New Zealand: a review with some policy implications. NZ Med J 1987;100:231-4.
31. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax 1995;50:303-11.
32. Lanes SF, Birmann B, Raiford D, Walker AM. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. J Clin Epidemiol 1997;50:321-8.
33. Asthma mortality in Latin America. J Invest Allergol Clin Immunol 1997;7:249-53.
34. Sly RM. Decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 2000;85:121-7.
35. Han P, Cole RP. Evolving differences in the presentation of status asthmaticus requiring intensive care unit admission. Chest 2002;122(Suppl):88.
36. Seale J. Asthma deaths: where are we now? Aust NZJ Med 1991;21:678-9.
37. th ed. London: Churchill-Livingstone, 1996; p. 165-89.
38. McFadden ER, Warren EL. Observations on asthma mortality. Ann Intern Med 1997;127:142-7.
39. Miller TP, Greenberger PA, Patterson R. The diagnosis of potentially fatal asthma in hospitalized adults. Patient characteristics and increased severity of asthma. Chest 1992;102:515-8.
40. Hart SR, Davidson AC. Acute adult asthma-assessment of severity and management and comparison with British Thoracic Society Guidelines. Respir Med 1999;93:8-10.
41. Hannaway PJ. Demographic characteristics of patients experiencing near-fatal and fatal asthma: results of a regional survey of 400 asthma specialists. Ann Allergy Asthma Immunol 2000;84:587-93.
42. Kolbe J, Fergusson W, Vamos M, Garret J. Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack. Thorax 2000;55:1007-15.
43. Moore BB, Wagner R, Weiss KB. A community-based study of near-fatal asthma. Ann Allergy Asthma Immunol 2001;86:190-5.
44. Mitchell I, Tough S, Semple LK, Green FH, Hessel PA. Near-fatal asthma. A population-based study of risks factors. Chest 2002;121:1407-13.
45. Reed S, Diggle S, Cushley MJ, Sleet RA, Tattersfield AE. Assessment and management of asthma in an accident and emergency department. Thorax 1985;40:897-902.
46. Hessel PA, Mitchell I, Tough S, Green FHY, Cockcroft D, Kepron W, et al. Risk factors for death from asthma. Ann Allergy Asthma Immunol 1999;83:362-8.
47. Suissa S, Hemmelgarn B, Blais L, Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 1996;154:1598-602.
48. Lanes SF, García Rodríguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax 2002;57:683-6.
49. Comparison of regularly schedule with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-7.
50. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
51. Tattersfield AE, Lofdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, et al. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet 2001;357:257-61.
52. Tan KS, Grove A, Mc Lean A, Gnosspelius Y, Hall IP, Lipworth BJ. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med 1997;156:28-35.
53. Moudgil H, Honeybourne D. Differences in asthma management between white European and Indian subcontinent ethnic groups living in socioeconomically deprived areas in the Birmingham (UK) conurbation. Thorax 1998;53:490-4.
54. Kolbe J, Fergusson W, Vamos M, Garret J. Case-control study of severe life threatening asthma (SLTA) in adults: psychological factors. Thorax 2002;57:317-22.
55. Mitchell I, Tough SC, Semple LK, Green FH, Hessel PA. Near-fatal asthma. A population-based study of risk factors. Chest 2002;121:1407-13.
56. Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002;122:1633-7.
57. 2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998;158:787-91.
58. Increased morbidity and mortality related to asthma among asthmatics patients who use major tranquilizers. BMJ 1996;312:79-82.
59. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994;330:1329-34.
60. Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 2002;121:329-33.
61. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatics and normal subjects as measured as simple awareness scale. Thorax 1992;47:410-3.
62. Near fatal asthma: clinical and physiological features, perception of bronchoconstriction, and psychological profile. J Allergy Clin Immunol 1991;88:838-46.
63. Webster KE, Colrain IM. P3-specific amplitude reductions to respiratory and auditory stimuli in subjects with asthma. Am J Respir Crit Care Med 2002,166:47-52.
64. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Disd Chest 1977;71:73-86.
65. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-63.
66. Wright W, Zhang YG, Salome CM, Woolcock AJ. Effect of inhaled preservatives on asthmatic subjects. I. Sodium metabisulfite. Am Rev Respir Dis 1990;141:1400-4.
67. Aspirin-intolerance as a precipitant factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989;2:127-9.
68. Levenson T, Greenberger PA, Donoghue ER, Lifschultz BD. Asthma death confounded by substance abuse. An assessment of fatal asthma. Chest 1996;110:604-10.
69. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000;117:1324-9.
70. Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorezuk DO. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 2003;123:510-7.
71. Antó JM, Sunyer JM. Epidemic asthma. En: Holgate ST, Boushey HA, Fabbri LM, editores. Difficult asthma. London: Martin Dunitz Ltd., 1999; p. 333-40.
72. Nannini LJ. Asma potencialmente fatal. Arch Bronconeumol 1997;33:462-71.
73. Kolbe J, Fergusson W, Garrett J. Rapid onset asthma: a severe but uncommon manifestation. Thorax 1998;53:241-7.
74. Woodruff PG, Edmond SD, Singh AK, Camargo CA. Sudden-onset severe acute asthma: clinical features and response to therapy. Acad Emerg Med 1998;5:695-701.
75. Barr RG, Woodruff PG, Clarck S, Camargo CA. Sudden-onset asthma exacerbations: clinical features, response to therapy, and 2-week follow-up. Eur Respir J 2000;15:266-73.
76. Rodrigo GJ, Rodrigo C. Rapid-onset asthma attack: a prospective cohort study about characteristics and response to the emergency department treatment. Chest 2000;118:1547-52.
77. Kallenbach JM, Frankel AH, Lapinsky SE, Thornton AS, Blott JA, Smith C, et al. Determinants of near fatality in acute severe asthma. Am J Med 1993;95:265-72.
78. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713-9.
79. Rossi A, Ganassini A, Brusasco V. Airflow obstruction and dynamic pulmonary hyperinflation. En: Hall JB, Corbridge T, Rodrigo C, Rodrigo GJ, editores. Acute asthma. Assessment and management. New York: McGraw-Hill, 2000; p. 57-82.
80. Pinsky MR. Cardiopulmonary interactions associated with airflow obstruction. En: Hall JB, Corbridge T, Rodrigo C, Rodrigo GJ, editores. Acute asthma. Assessment and management. New York: McGraw-Hill, 2000; p. 105-23.
81. McFadden ER, Lyons H. Arterial blood gas tension in asthma. N Engl J Med 1968;278:1027-32.
82. Rodríguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J 1997;10:1359-71.
83. Rodríguez-Roisin R. Gas exchange in acute asthma. En: Hall JB, Corbridge T, Rodrigo C, Rodrigo GJ, editores. Acute asthma. Assessment and management. New York: McGraw-Hill, 2000; p. 83-103.
84. Rodríguez-Roisin R, Ballester E, Torres A, Roca J, Wagner PD. Mechanisms of abnormal gas exchange in patients with status asthmaticus needing mechanical ventilation. Am Rev Respir Dis 1989;139:732-9.
85. Roca J, Ramis L, Rodríguez-Roisin R, Ballester E, Montserrat JM, Wagner PD. Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization. Am Rev Respir Dis 1988;137:1055-61.
86. Ballester E, Reyes R, Roca J, Guitart R, Wagner PD, Rodríguez Roisin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989;44:258-67.
87. Diamond JP, Palazzo MG. An unconscious man with asthma and a fixed dilated pupil. Lancet 1997;349:98.
88. Gaussorgues P, Piperno D, Fouqué P, Voyer F, Robert D. Hypertension intracranienne au cours de l'etat asthmatique. Ann Fr Anesth Reanim 1987;6:38-41.
89. Zender HO, Eggimann P, Bulpa P, Chevrolet JC, Jolliet P. Quadriparesia following permissive hypercapnia and inhalational anesthesia in a patient with severe status asthmaticus. Intensive Care Med 1996;22:1001.
90. Rodrigo C, Rodrigo G. Subarachnoid hemorrhage following permissive hypercapnia in a patient with severe acute asthma. Am J Emerg Med 1999;17:697-9.
91. Rodríguez Roisin R, Torres A, Agusti AG, Ussetti P, Agusti-Vidal A. Subconjunctival haemorrhage: a feature of acute severe asthma. Postgrad Med 1985;61:579-81.
92. Robin ED, McCauley R. Sudden cardiac deaths in bronchial asthma and inhaled beta-agonists. Chest 1992;101:1699-702.
93. Burggraaf J, Westendorp RG, In't Veen JC, Schoemaker RC, Sterk PJ, Cohen AF, et al. Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax 2001;56:506-7.
94. Imman WHW, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use pressurised aerosols. Lancet 1969;2:279-85.
95. Fraser PM, Speizer FE, Waters SDM, Doll R, Mann NM. The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest 1971;65:71-84.
96. Gandevia B. Pressurised sympathomimetic aerosols and their lack of relationship to asthma mortality in Australia. Med J Aust 1973;1:273-7.
97. Keating G, Mitchell EA, Jackson R, Beaglehole R, Rea H. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. BMJ J 1984;289:348-51.
98. Spitzer WO, Suissa S, Ernst P, Horowitz RI, Habbick B, Cockroft D, et al. The use of β-agonists and the risk of death and near-death from asthma. N Engl J Med 1992;326:501-6.
99. Burgess C, Pearce N, Thiruchelvam R, Wilkinson R, Linaker C, Woodman K, et al. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J 1994;7:498-503.
100. Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B, Horwitz RI, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268:3462-4.
101. Rodrigo C, Rodrigo G. High-dose MDI salbutamol treatment of asthma in the ED. Am J Emerg Med 1995;13:21-6.
102. Rodrigo G, Rodrigo C. Metered dose inhaler salbutamol treatment of asthma in the ED: Comparison of two doses with plasma levels. Am J Emerg Med 1996;14:144-50.
103. Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. Respiratory arrest in near-fatal asthma. N Engl J Med 1991;324:285-8.
104. Bai TR, Cooper J, Koelmeyer T, Pare PD, Weir TD. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med 2000;162:663-9.
105. Rodrigo GJ, Rodrigo C. Emergency department assessment: severity and outcome prediction. En: Hall JB, Corbridge T, Rodrigo C, Rodrigo GJ, editores. Acute asthma. Assessment and management. New York: McGraw-Hill, 2000; p. 125-38.
106. Rodrigo C, Rodrigo G. Treatment of acute asthma. Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with spacer. Chest 1994;106:1071-6.
107. Rodrigo G, Rodrigo C. Effect of age on bronchodilator response in the acute asthma treatment. Chest 1997;112:19-23.
108. McFadden ER, Kiser R, De Groot WJ. Acute bronchial asthma: relations between clinical and physiologic manifestations. N Engl J Med 1973;288;221-5.
109. Pearson MG, Spence DP, Ryland L, Harrison BDW. Value of pulsus paradoxus in assessing acute severe asthma. BMJ 1993;307:659.
110. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review [in press]. Chest.
111. Rodrigo GJ. Oxygen treatment of acute severe asthma. Oxygen saturation may help identify patients in need of intensive management. BMJ 2001;323:1069.
112. Nannini LJ Jr. Observations about fatal and near fatal asthma. International Review of Asthma 2002;3:64-9.
113. Martínez-Moragóna E, Perpiñá M, Bellochc A, De Diego A, Martínez-Francés ME. Percepción de la disnea durante la bronco-constricción aguda en los pacientes con asma. Arch Bronconeumol 2003;39:67-73.
114. In't Veen JCCM, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000;161:1902-6.
115. Lutchen KR, Jensen A, Atileh H, Kaczka DW, Israel E, Suki B, et al. Airway constriction pattern is a central component of asthma severity. Am J Respir Crit Care Med 2001;164:207-15.
116. Suissa S, Eenst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
117. Chien JW, Ciufo R, Novak R, Snowronski M, Nelson JA, Coreno A, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000;117:728-33.
118. Rodrigo GJ, Rodríguez Verde M, Peregalli V, Rodrigo C. The effects of short term 28 and 100 percent oxygen on arterial carbon dioxide tension and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003;124:1312-7.
119. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbations: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999;34:8-18.
120. Rodrigo GJ, Rodrigo C, Burschtin O. Ipratropium bromide in acute adult severe asthma: a meta-analysis of randomized controlled trials. Am J Med 1999;107:363-70.
121. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000;161:1862-8.
122. Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest 2002;121:1977-87.
123. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma. An evidence-based evaluation. Chest 1999;116:285-95.
124. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane Review). En: The Cochrane Library, Issue 4. Oxford, UK: Update Software, 2002.
125. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma (Cochrane Review). En: The Cochrane Library, Issue 4. Oxford, UK: Update Software, 2002.
126. Gibson PG, Power H, Caughlan J, Wilson AJ, Hensley MJ, Abramson M, et al. Limited (information only) patient education programs for adults with asthma (Cochrane Review). En: The Cochrane Library, Issue 1. Oxford, UK: Update Software, 2003.
127. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma (Cochrane Review). En: The Cochrane Library, Issue 1. Oxford, UK:Update Software, 2003.
128. Molfino NA, Nannini LJ, Rebuck AS, Slutsky AS. Follow-up study after near-fatal attacks. Chest 1992;101:621-3.
129. Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq JM, et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992;146:76-81.
130. Nannini LJ Jr. Impacto de un programa de atención sobre la morbimortalidad por asma. Revista Círculo Médico Rosario 2000;66:19-23.